 Technical details of Camelina's genome sequence were published on April 23, 2014 in the academic journal Nature Communications.In 2013 Rothamsted Research in the UK reported they had developed a genetically modified form of Camelina sativa that produced Eicosapentaenoic acid (EPA) and Docosahexaenoic acid (DHA).EPA and DHA are omega-3 fatty acids which are beneficial for cardiovascular health.